Postoperative Cognitive Dysfunction Completed Phase 4 Trials for Sevoflurane (DB01236)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02662257Impact of Anesthesia Maintenance Methods on Incidence of Postoperative DeliriumPrevention